- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06115447
Polypropylene vs Polyglactin in Suturing of the Lung
October 29, 2023 updated by: Ahmad Mohammad Younus, Assiut University
Comparative study comparing polypropylene and Polyglactin in suturing of the lung
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Lung tear or, pulmonary laceration is an injury in lung parenchyma, said injury can be caused by several reasons:
Blunt chest trauma Penetrating trauma such as stab wounds or firearm wounds Iatrogenic, such as faulty intercostal tube insertion
Study Type
Observational
Enrollment (Estimated)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
All patients presented to cardiothoracic surgery department and trauma department with the inclusion criteria applied
Description
Inclusion Criteria:
- Patients admitted to Assiut University Hospital And will undergo surgery for lung tear repair.
- Patients admitted to Assiut University Hospital And will undergo surgery for bullectomy or lobectomy.
Exclusion Criteria:
- Patients with lung injury repaired with a stapler
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Polyglactin group
lung suturing with polyglactin
|
lung suturing with polyglactin
|
|
Polypropylene Arm
lung suturing with Polypropylene
|
ung suturing with polypropylene
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration in days of intercostal tube air leak with each group
Time Frame: 2 weeks
|
Polypropylene vs Polyglactin
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Regan T, Lawrence N. Comparison of poliglecaprone-25 and polyglactin-910 in cutaneous surgery. Dermatol Surg. 2013 Sep;39(9):1340-4. doi: 10.1111/dsu.12265. Epub 2013 Aug 13.
- Rendeki S, Molnar TF. Pulmonary contusion. J Thorac Dis. 2019 Feb;11(Suppl 2):S141-S151. doi: 10.21037/jtd.2018.11.53.
- Romby P, Carbon P, Westhof E, Ehresmann C, Ebel JP, Ehresmann B, Giege R. Importance of conserved residues for the conformation of the T-loop in tRNAs. J Biomol Struct Dyn. 1987 Dec;5(3):669-87. doi: 10.1080/07391102.1987.10506419.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 15, 2024
Primary Completion (Estimated)
April 30, 2026
Study Completion (Estimated)
October 30, 2028
Study Registration Dates
First Submitted
October 11, 2023
First Submitted That Met QC Criteria
October 29, 2023
First Posted (Estimated)
November 3, 2023
Study Record Updates
Last Update Posted (Estimated)
November 3, 2023
Last Update Submitted That Met QC Criteria
October 29, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- polyglactin lung suturing
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.